Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice

Journal of Physiology

Volumn 593, Issue 1, 2015, Pages 231-243

  Bjorefeldt, Andreas ^a   Andreasson, Ulf ^a   Daborg, Jonny ^a   Riebe, Ilse ^a   Wasling, Pontus ^a   Zetterberg, Henrik ^a,b   Hanse, Eric ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTION POTENTIAL; ANIMAL; CEREBROSPINAL FLUID; FEMALE; HIPPOCAMPAL CA1 REGION; HUMAN; IN VITRO STUDY; MALE; NEOCORTEX; PHYSIOLOGY; PYRAMIDAL NERVE CELL; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; CA1 REGION, HIPPOCAMPAL; CEREBROSPINAL FLUID; FEMALE; HUMANS; IN VITRO TECHNIQUES; MALE; NEOCORTEX; PYRAMIDAL CELLS; RATS, WISTAR;

EID: 84920168149     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.284711     Document Type: Article

References (28)

1. Alfredsson G, Wiesel FA & Tylec A (1988). Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 23, 689-697.
2. Audinat E, Hermel JM & Crepel F (1989). Neurotensin-induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro. Exp Brain Res 78, 358-368.
3. Bender KJ, Ford CP & Trussell LO (2012). Dopaminergic modulation of axon initial segment calcium channels regulates action potential initiation. Neuron 68, 500-511.
4. Brightman MW & Palay SL (1963). The fine structure of ependyma in the brain of the rat. J Cell Biol 19, 415-439.
5. Brightman MW & Reese TS (1969). Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 40, 648-677.
6. Buma P, Veening J & Nieuwenhuys R (1989). Ultrastructural characterization of adrenocorticotrope hormone (ACTH) immunoreactive fibres in the mesencephalic central grey substance of the rat. Eur J Neurosci 1, 659-672.
7. Burtis CA, Ashwood ER & Bruns DE (2006). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier Saunders, St Louis, MO.
8. Buvanendran A, Kroin JS, Della Valle CJ, Moric M & Tuman KJ (2012). Cerebrospinal fluid neurotransmitter changes during the perioperative period in patients undergoing total knee replacement: a randomized trial. Anesth Analg 114, 434-441.
9. Calle M, Claassen IE, Veening JG, Kozicz T, Roubos EW & Barendregt HP (2005). Opioid peptides, CRF, and urocortin in cerebrospinal fluid-contacting neurons in Xenopus laevis. Ann NY Acad Sci 1040, 249-252.
10. + channels: an unexpected form of cellular plasticity. Nat Rev Neurosci 2, 397-407.
11. Coccaro EF, Lee R & Vezina P (2013). Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects. J Psychiatr Res 47, 1247-1253.
12. Cupedo RN & de Weerd H (1980). Serotonergic intraventricular axons in the habenular region. Phagocytosis after induced degeneration. Anat Embryol (Berl) 158, 213-226.
13. Destexhe A, Rudolph M & Pare D (2003). The high-conductance state of neocortical neurons in vivo. Nat Rev Neurosci 4, 739-751.
14. Fellous JM, Rudolph M, Destexhe A & Sejnowski TJ (2003). Synaptic background noise controls the input/output characteristics of single cells in an in vitro model of in vivo activity. Neuroscience 122, 811-829.
15. Fiszman ML, Ricart KC, Latini A, Rodriguez G & Sica RE (2010). In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Acta Neurol Scand 121, 120-126.
16. Goldstein DA & Massry SG (1980). Divalent ions in blood and cerebrospinal fluid: effect of hypercalcemia, hyperphosphatemia, renal failure and parathyroid hormone. Adv Exp Med Biol 128, 289-297.
17. Haas HL & Gahwiler BH (1992). Vasoactive intestinal polypeptide modulates neuronal excitability in hippocampal slices of the rat. Neuroscience 47, 273-277.
18. Jackson IMD ( 1980). Significance and function of neuropeptides in cerebrospinal fluid. In Neurobiology of Cerebrospinal Fluid, ed. Wood JH, pp. 625-644. Plenum Press, New York.
19. Joborn C, Hetta J, Niklasson F, Rastad J, Wide L, Agren H, Akerstrom G & Ljunghall S (1991). Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinology 16, 311-322.
20. Nicholson C (1999). Signals that go with the flow. Trends Neurosci 22, 143-145.
21. Parent A (1981). Comparative anatomy of the serotoninergic systems. J Physiol (Paris) 77, 147-156.
22. Post RM, Rubinow DR, Kling MA, Berrettini W & Gold PW (1988). Neuroactive substances in cerebrospinal-fluid - normal and pathological regulatory mechanisms. Ann NY Acad Sci 531, 15-28.
23. Smith DE, Johanson CE & Keep RF (2004). Peptide and peptide analog transport systems at the blood-CSF barrier. Adv Drug Deliv Rev 56, 1765-1791.
24. Steriade M, Timofeev I & Grenier F (2001). Natural waking and sleep states: a view from inside neocortical neurons. J Neurophysiol 85, 1969-1985.
25. Wang S, Zhang AP, Kurada L, Matsui T & Lei S (2011). Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels. J Neurophysiol 106, 1515-1524.
26. Veening JG & Barendregt HP (2010). The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review. Cerebrospinal Fluid Res 7, 1.
27. Vigh B, Manzano e Silva MJ, Frank CL, Vincze C, Czirok SJ, Szabo A, Lukats A & Szel A (2004). The system of cerebrospinal fluid-contacting neurons. Its supposed role in the nonsynaptic signal transmission of the brain. Histol Histopathol 19, 607-628.
28. Yan J, He C, Xia JX, Zhang D & Hu ZA (2012). Orexin-A excites pyramidal neurons in layer 2/3 of the rat prefrontal cortex. Neurosci Lett 520, 92-97.